BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 21184748)

  • 1. Soraphen A, an inhibitor of acetyl CoA carboxylase activity, interferes with fatty acid elongation.
    Jump DB; Torres-Gonzalez M; Olson LK
    Biochem Pharmacol; 2011 Mar; 81(5):649-60. PubMed ID: 21184748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of acetyl-CoA carboxylases by soraphen A prevents lipid accumulation and adipocyte differentiation in 3T3-L1 cells.
    Cordonier EL; Jarecke SK; Hollinger FE; Zempleni J
    Eur J Pharmacol; 2016 Jun; 780():202-8. PubMed ID: 27041646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical inhibition of acetyl-CoA carboxylase induces growth arrest and cytotoxicity selectively in cancer cells.
    Beckers A; Organe S; Timmermans L; Scheys K; Peeters A; Brusselmans K; Verhoeven G; Swinnen JV
    Cancer Res; 2007 Sep; 67(17):8180-7. PubMed ID: 17804731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soraphen, an inhibitor of the acetyl-CoA carboxylase system, improves peripheral insulin sensitivity in mice fed a high-fat diet.
    Schreurs M; van Dijk TH; Gerding A; Havinga R; Reijngoud DJ; Kuipers F
    Diabetes Obes Metab; 2009 Oct; 11(10):987-91. PubMed ID: 19519866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells.
    Berod L; Friedrich C; Nandan A; Freitag J; Hagemann S; Harmrolfs K; Sandouk A; Hesse C; Castro CN; Bähre H; Tschirner SK; Gorinski N; Gohmert M; Mayer CT; Huehn J; Ponimaskin E; Abraham WR; Müller R; Lochner M; Sparwasser T
    Nat Med; 2014 Nov; 20(11):1327-33. PubMed ID: 25282359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isozyme-nonselective N-substituted bipiperidylcarboxamide acetyl-CoA carboxylase inhibitors reduce tissue malonyl-CoA concentrations, inhibit fatty acid synthesis, and increase fatty acid oxidation in cultured cells and in experimental animals.
    Harwood HJ; Petras SF; Shelly LD; Zaccaro LM; Perry DA; Makowski MR; Hargrove DM; Martin KA; Tracey WR; Chapman JG; Magee WP; Dalvie DK; Soliman VF; Martin WH; Mularski CJ; Eisenbeis SA
    J Biol Chem; 2003 Sep; 278(39):37099-111. PubMed ID: 12842871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic de novo lipogenesis is present in liver-specific ACC1-deficient mice.
    Harada N; Oda Z; Hara Y; Fujinami K; Okawa M; Ohbuchi K; Yonemoto M; Ikeda Y; Ohwaki K; Aragane K; Tamai Y; Kusunoki J
    Mol Cell Biol; 2007 Mar; 27(5):1881-8. PubMed ID: 17210641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-chain fatty acids inhibit acetyl-CoA carboxylase gene expression in the pancreatic beta-cell line INS-1.
    Brun T; Assimacopoulos-Jeannet F; Corkey BE; Prentki M
    Diabetes; 1997 Mar; 46(3):393-400. PubMed ID: 9032094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary long-chain unsaturated fatty acids acutely and differently reduce the activities of lipogenic enzymes and of citrate carrier in rat liver.
    Gnoni A; Giudetti AM
    J Physiol Biochem; 2016 Sep; 72(3):485-94. PubMed ID: 27312217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetyl-CoA carboxylase-a as a novel target for cancer therapy.
    Wang C; Rajput S; Watabe K; Liao DF; Cao D
    Front Biosci (Schol Ed); 2010 Jan; 2(2):515-26. PubMed ID: 20036965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetyl-CoA Carboxylase Inhibition Improves Multiple Dimensions of NASH Pathogenesis in Model Systems.
    Ross TT; Crowley C; Kelly KL; Rinaldi A; Beebe DA; Lech MP; Martinez RV; Carvajal-Gonzalez S; Boucher M; Hirenallur-Shanthappa D; Morin J; Opsahl AC; Vargas SR; Bence KK; Pfefferkorn JA; Esler WP
    Cell Mol Gastroenterol Hepatol; 2020; 10(4):829-851. PubMed ID: 32526482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GS-0976 (Firsocostat): an investigational liver-directed acetyl-CoA carboxylase (ACC) inhibitor for the treatment of non-alcoholic steatohepatitis (NASH).
    Alkhouri N; Lawitz E; Noureddin M; DeFronzo R; Shulman GI
    Expert Opin Investig Drugs; 2020 Feb; 29(2):135-141. PubMed ID: 31519114
    [No Abstract]   [Full Text] [Related]  

  • 13. Acetyl-CoA carboxylase 1 regulates endothelial cell migration by shifting the phospholipid composition.
    Glatzel DK; Koeberle A; Pein H; Löser K; Stark A; Keksel N; Werz O; Müller R; Bischoff I; Fürst R
    J Lipid Res; 2018 Feb; 59(2):298-311. PubMed ID: 29208696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5'-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase.
    Kudo N; Barr AJ; Barr RL; Desai S; Lopaschuk GD
    J Biol Chem; 1995 Jul; 270(29):17513-20. PubMed ID: 7615556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver Fatty Acid Composition and Inflammation in Mice Fed with High-Carbohydrate Diet or High-Fat Diet.
    da Silva-Santi LG; Antunes MM; Caparroz-Assef SM; Carbonera F; Masi LN; Curi R; Visentainer JV; Bazotte RB
    Nutrients; 2016 Oct; 8(11):. PubMed ID: 27801862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation.
    Kim CW; Addy C; Kusunoki J; Anderson NN; Deja S; Fu X; Burgess SC; Li C; Ruddy M; Chakravarthy M; Previs S; Milstein S; Fitzgerald K; Kelley DE; Horton JD
    Cell Metab; 2017 Aug; 26(2):394-406.e6. PubMed ID: 28768177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart.
    Saddik M; Gamble J; Witters LA; Lopaschuk GD
    J Biol Chem; 1993 Dec; 268(34):25836-45. PubMed ID: 7902355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acid biosynthesis in Erlich cells. The mechanism of short term control by exogenous free fatty acids.
    McGee R; Spector AA
    J Biol Chem; 1975 Jul; 250(14):5419-25. PubMed ID: 237919
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Stüve P; Minarrieta L; Erdmann H; Arnold-Schrauf C; Swallow M; Guderian M; Krull F; Hölscher A; Ghorbani P; Behrends J; Abraham WR; Hölscher C; Sparwasser TD; Berod L
    Front Immunol; 2018; 9():495. PubMed ID: 29675017
    [No Abstract]   [Full Text] [Related]  

  • 20. Palmitic acid (16:0) competes with omega-6 linoleic and omega-3 ɑ-linolenic acids for FADS2 mediated Δ6-desaturation.
    Park HG; Kothapalli KSD; Park WJ; DeAllie C; Liu L; Liang A; Lawrence P; Brenna JT
    Biochim Biophys Acta; 2016 Feb; 1861(2):91-97. PubMed ID: 26597785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.